 | • レポートコード：MRC308GR11538 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のRAS作用剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のRAS作用剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– RAS作用剤の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
RAS作用剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・ACE阻害薬、アンジオテンシンII受容体拮抗薬（ARB）、レニン阻害薬、アルドステロン拮抗薬、その他（利尿薬）
用途別セグメント
・病院薬局、小売薬局、オンライン薬局
主要な市場プレーヤー
・Novartis AG、Pfizer, Inc.、AstraZeneca plc、Merck & Co., Inc.、Sanofi S.A.、Bristol-Myers Squibb Company、Daiichi Sankyo Company, Limited、Takeda Pharmaceutical Company Limited、Boehringer Ingelheim GmbH、Johnson & Johnson
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、RAS作用剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なRAS作用剤メーカーの企業概要、2019年～2022年までのRAS作用剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なRAS作用剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別RAS作用剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのRAS作用剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのRAS作用剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびRAS作用剤の産業チェーンを掲載しています。
・第14、15章では、RAS作用剤の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– RAS作用剤の概要
– 種類別分析（2018年vs2022年vs2029年）：ACE阻害薬、アンジオテンシンII受容体拮抗薬（ARB）、レニン阻害薬、アルドステロン拮抗薬、その他（利尿薬）
– 用途別分析（2018年vs2022年vs2029年）：病院薬局、小売薬局、オンライン薬局
– 世界のRAS作用剤市場規模・予測
– 世界のRAS作用剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Novartis AG、Pfizer, Inc.、AstraZeneca plc、Merck & Co., Inc.、Sanofi S.A.、Bristol-Myers Squibb Company、Daiichi Sankyo Company, Limited、Takeda Pharmaceutical Company Limited、Boehringer Ingelheim GmbH、Johnson & Johnson
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：ACE阻害薬、アンジオテンシンII受容体拮抗薬（ARB）、レニン阻害薬、アルドステロン拮抗薬、その他（利尿薬）
・用途別分析2018年-2029年：病院薬局、小売薬局、オンライン薬局
・RAS作用剤の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・RAS作用剤のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・RAS作用剤のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・RAS作用剤の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・RAS作用剤の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of RAS-acting Agents
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global RAS-acting Agents Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 ACE Inhibitors
1.3.3 Angiotensin II Receptor Blockers (ARBs)
1.3.4 Renin Inhibitors
1.3.5 Aldosterone Antagonists
1.3.6 Others (diuretics)
1.4 Market Analysis by Application
1.4.1 Overview: Global RAS-acting Agents Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global RAS-acting Agents Market Size & Forecast
1.5.1 Global RAS-acting Agents Consumption Value (2018 & 2022 & 2029)
1.5.2 Global RAS-acting Agents Sales Quantity (2018-2029)
1.5.3 Global RAS-acting Agents Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG RAS-acting Agents Product and Services
2.1.4 Novartis AG RAS-acting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis AG Recent Developments/Updates
2.2 Pfizer, Inc.
2.2.1 Pfizer, Inc. Details
2.2.2 Pfizer, Inc. Major Business
2.2.3 Pfizer, Inc. RAS-acting Agents Product and Services
2.2.4 Pfizer, Inc. RAS-acting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer, Inc. Recent Developments/Updates
2.3 AstraZeneca plc
2.3.1 AstraZeneca plc Details
2.3.2 AstraZeneca plc Major Business
2.3.3 AstraZeneca plc RAS-acting Agents Product and Services
2.3.4 AstraZeneca plc RAS-acting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AstraZeneca plc Recent Developments/Updates
2.4 Merck & Co., Inc.
2.4.1 Merck & Co., Inc. Details
2.4.2 Merck & Co., Inc. Major Business
2.4.3 Merck & Co., Inc. RAS-acting Agents Product and Services
2.4.4 Merck & Co., Inc. RAS-acting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck & Co., Inc. Recent Developments/Updates
2.5 Sanofi S.A.
2.5.1 Sanofi S.A. Details
2.5.2 Sanofi S.A. Major Business
2.5.3 Sanofi S.A. RAS-acting Agents Product and Services
2.5.4 Sanofi S.A. RAS-acting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi S.A. Recent Developments/Updates
2.6 Bristol-Myers Squibb Company
2.6.1 Bristol-Myers Squibb Company Details
2.6.2 Bristol-Myers Squibb Company Major Business
2.6.3 Bristol-Myers Squibb Company RAS-acting Agents Product and Services
2.6.4 Bristol-Myers Squibb Company RAS-acting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.7 Daiichi Sankyo Company, Limited
2.7.1 Daiichi Sankyo Company, Limited Details
2.7.2 Daiichi Sankyo Company, Limited Major Business
2.7.3 Daiichi Sankyo Company, Limited RAS-acting Agents Product and Services
2.7.4 Daiichi Sankyo Company, Limited RAS-acting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Daiichi Sankyo Company, Limited Recent Developments/Updates
2.8 Takeda Pharmaceutical Company Limited
2.8.1 Takeda Pharmaceutical Company Limited Details
2.8.2 Takeda Pharmaceutical Company Limited Major Business
2.8.3 Takeda Pharmaceutical Company Limited RAS-acting Agents Product and Services
2.8.4 Takeda Pharmaceutical Company Limited RAS-acting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.9 Boehringer Ingelheim GmbH
2.9.1 Boehringer Ingelheim GmbH Details
2.9.2 Boehringer Ingelheim GmbH Major Business
2.9.3 Boehringer Ingelheim GmbH RAS-acting Agents Product and Services
2.9.4 Boehringer Ingelheim GmbH RAS-acting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Boehringer Ingelheim GmbH Recent Developments/Updates
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson RAS-acting Agents Product and Services
2.10.4 Johnson & Johnson RAS-acting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Johnson & Johnson Recent Developments/Updates
3 Competitive Environment: RAS-acting Agents by Manufacturer
3.1 Global RAS-acting Agents Sales Quantity by Manufacturer (2018-2023)
3.2 Global RAS-acting Agents Revenue by Manufacturer (2018-2023)
3.3 Global RAS-acting Agents Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of RAS-acting Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 RAS-acting Agents Manufacturer Market Share in 2022
3.4.2 Top 6 RAS-acting Agents Manufacturer Market Share in 2022
3.5 RAS-acting Agents Market: Overall Company Footprint Analysis
3.5.1 RAS-acting Agents Market: Region Footprint
3.5.2 RAS-acting Agents Market: Company Product Type Footprint
3.5.3 RAS-acting Agents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global RAS-acting Agents Market Size by Region
4.1.1 Global RAS-acting Agents Sales Quantity by Region (2018-2029)
4.1.2 Global RAS-acting Agents Consumption Value by Region (2018-2029)
4.1.3 Global RAS-acting Agents Average Price by Region (2018-2029)
4.2 North America RAS-acting Agents Consumption Value (2018-2029)
4.3 Europe RAS-acting Agents Consumption Value (2018-2029)
4.4 Asia-Pacific RAS-acting Agents Consumption Value (2018-2029)
4.5 South America RAS-acting Agents Consumption Value (2018-2029)
4.6 Middle East and Africa RAS-acting Agents Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global RAS-acting Agents Sales Quantity by Type (2018-2029)
5.2 Global RAS-acting Agents Consumption Value by Type (2018-2029)
5.3 Global RAS-acting Agents Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global RAS-acting Agents Sales Quantity by Application (2018-2029)
6.2 Global RAS-acting Agents Consumption Value by Application (2018-2029)
6.3 Global RAS-acting Agents Average Price by Application (2018-2029)
7 North America
7.1 North America RAS-acting Agents Sales Quantity by Type (2018-2029)
7.2 North America RAS-acting Agents Sales Quantity by Application (2018-2029)
7.3 North America RAS-acting Agents Market Size by Country
7.3.1 North America RAS-acting Agents Sales Quantity by Country (2018-2029)
7.3.2 North America RAS-acting Agents Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe RAS-acting Agents Sales Quantity by Type (2018-2029)
8.2 Europe RAS-acting Agents Sales Quantity by Application (2018-2029)
8.3 Europe RAS-acting Agents Market Size by Country
8.3.1 Europe RAS-acting Agents Sales Quantity by Country (2018-2029)
8.3.2 Europe RAS-acting Agents Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific RAS-acting Agents Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific RAS-acting Agents Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific RAS-acting Agents Market Size by Region
9.3.1 Asia-Pacific RAS-acting Agents Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific RAS-acting Agents Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America RAS-acting Agents Sales Quantity by Type (2018-2029)
10.2 South America RAS-acting Agents Sales Quantity by Application (2018-2029)
10.3 South America RAS-acting Agents Market Size by Country
10.3.1 South America RAS-acting Agents Sales Quantity by Country (2018-2029)
10.3.2 South America RAS-acting Agents Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa RAS-acting Agents Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa RAS-acting Agents Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa RAS-acting Agents Market Size by Country
11.3.1 Middle East & Africa RAS-acting Agents Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa RAS-acting Agents Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 RAS-acting Agents Market Drivers
12.2 RAS-acting Agents Market Restraints
12.3 RAS-acting Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of RAS-acting Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of RAS-acting Agents
13.3 RAS-acting Agents Production Process
13.4 RAS-acting Agents Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 RAS-acting Agents Typical Distributors
14.3 RAS-acting Agents Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global RAS-acting Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global RAS-acting Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG RAS-acting Agents Product and Services
Table 6. Novartis AG RAS-acting Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis AG Recent Developments/Updates
Table 8. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer, Inc. Major Business
Table 10. Pfizer, Inc. RAS-acting Agents Product and Services
Table 11. Pfizer, Inc. RAS-acting Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer, Inc. Recent Developments/Updates
Table 13. AstraZeneca plc Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca plc Major Business
Table 15. AstraZeneca plc RAS-acting Agents Product and Services
Table 16. AstraZeneca plc RAS-acting Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. AstraZeneca plc Recent Developments/Updates
Table 18. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Merck & Co., Inc. Major Business
Table 20. Merck & Co., Inc. RAS-acting Agents Product and Services
Table 21. Merck & Co., Inc. RAS-acting Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck & Co., Inc. Recent Developments/Updates
Table 23. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi S.A. Major Business
Table 25. Sanofi S.A. RAS-acting Agents Product and Services
Table 26. Sanofi S.A. RAS-acting Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi S.A. Recent Developments/Updates
Table 28. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 29. Bristol-Myers Squibb Company Major Business
Table 30. Bristol-Myers Squibb Company RAS-acting Agents Product and Services
Table 31. Bristol-Myers Squibb Company RAS-acting Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bristol-Myers Squibb Company Recent Developments/Updates
Table 33. Daiichi Sankyo Company, Limited Basic Information, Manufacturing Base and Competitors
Table 34. Daiichi Sankyo Company, Limited Major Business
Table 35. Daiichi Sankyo Company, Limited RAS-acting Agents Product and Services
Table 36. Daiichi Sankyo Company, Limited RAS-acting Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Daiichi Sankyo Company, Limited Recent Developments/Updates
Table 38. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 39. Takeda Pharmaceutical Company Limited Major Business
Table 40. Takeda Pharmaceutical Company Limited RAS-acting Agents Product and Services
Table 41. Takeda Pharmaceutical Company Limited RAS-acting Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 43. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim GmbH Major Business
Table 45. Boehringer Ingelheim GmbH RAS-acting Agents Product and Services
Table 46. Boehringer Ingelheim GmbH RAS-acting Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 48. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 49. Johnson & Johnson Major Business
Table 50. Johnson & Johnson RAS-acting Agents Product and Services
Table 51. Johnson & Johnson RAS-acting Agents Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Johnson & Johnson Recent Developments/Updates
Table 53. Global RAS-acting Agents Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global RAS-acting Agents Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global RAS-acting Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in RAS-acting Agents, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and RAS-acting Agents Production Site of Key Manufacturer
Table 58. RAS-acting Agents Market: Company Product Type Footprint
Table 59. RAS-acting Agents Market: Company Product Application Footprint
Table 60. RAS-acting Agents New Market Entrants and Barriers to Market Entry
Table 61. RAS-acting Agents Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global RAS-acting Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global RAS-acting Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global RAS-acting Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global RAS-acting Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global RAS-acting Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global RAS-acting Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global RAS-acting Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global RAS-acting Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global RAS-acting Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global RAS-acting Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global RAS-acting Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global RAS-acting Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global RAS-acting Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global RAS-acting Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global RAS-acting Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global RAS-acting Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global RAS-acting Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global RAS-acting Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America RAS-acting Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America RAS-acting Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America RAS-acting Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America RAS-acting Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America RAS-acting Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America RAS-acting Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America RAS-acting Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America RAS-acting Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe RAS-acting Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe RAS-acting Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe RAS-acting Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe RAS-acting Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe RAS-acting Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe RAS-acting Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe RAS-acting Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe RAS-acting Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific RAS-acting Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific RAS-acting Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific RAS-acting Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific RAS-acting Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific RAS-acting Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific RAS-acting Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific RAS-acting Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific RAS-acting Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America RAS-acting Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America RAS-acting Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America RAS-acting Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America RAS-acting Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America RAS-acting Agents Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America RAS-acting Agents Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America RAS-acting Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America RAS-acting Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa RAS-acting Agents Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa RAS-acting Agents Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa RAS-acting Agents Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa RAS-acting Agents Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa RAS-acting Agents Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa RAS-acting Agents Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa RAS-acting Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa RAS-acting Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 120. RAS-acting Agents Raw Material
Table 121. Key Manufacturers of RAS-acting Agents Raw Materials
Table 122. RAS-acting Agents Typical Distributors
Table 123. RAS-acting Agents Typical Customers
List of Figures
Figure 1. RAS-acting Agents Picture
Figure 2. Global RAS-acting Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global RAS-acting Agents Consumption Value Market Share by Type in 2022
Figure 4. ACE Inhibitors Examples
Figure 5. Angiotensin II Receptor Blockers (ARBs) Examples
Figure 6. Renin Inhibitors Examples
Figure 7. Aldosterone Antagonists Examples
Figure 8. Others (diuretics) Examples
Figure 9. Global RAS-acting Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global RAS-acting Agents Consumption Value Market Share by Application in 2022
Figure 11. Hospital Pharmacies Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Online Pharmacies Examples
Figure 14. Global RAS-acting Agents Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global RAS-acting Agents Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global RAS-acting Agents Sales Quantity (2018-2029) & (K Units)
Figure 17. Global RAS-acting Agents Average Price (2018-2029) & (US$/Unit)
Figure 18. Global RAS-acting Agents Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global RAS-acting Agents Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of RAS-acting Agents by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 RAS-acting Agents Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 RAS-acting Agents Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global RAS-acting Agents Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global RAS-acting Agents Consumption Value Market Share by Region (2018-2029)
Figure 25. North America RAS-acting Agents Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe RAS-acting Agents Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific RAS-acting Agents Consumption Value (2018-2029) & (USD Million)
Figure 28. South America RAS-acting Agents Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa RAS-acting Agents Consumption Value (2018-2029) & (USD Million)
Figure 30. Global RAS-acting Agents Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global RAS-acting Agents Consumption Value Market Share by Type (2018-2029)
Figure 32. Global RAS-acting Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global RAS-acting Agents Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global RAS-acting Agents Consumption Value Market Share by Application (2018-2029)
Figure 35. Global RAS-acting Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America RAS-acting Agents Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America RAS-acting Agents Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America RAS-acting Agents Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America RAS-acting Agents Consumption Value Market Share by Country (2018-2029)
Figure 40. United States RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe RAS-acting Agents Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe RAS-acting Agents Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe RAS-acting Agents Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe RAS-acting Agents Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific RAS-acting Agents Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific RAS-acting Agents Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific RAS-acting Agents Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific RAS-acting Agents Consumption Value Market Share by Region (2018-2029)
Figure 56. China RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America RAS-acting Agents Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America RAS-acting Agents Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America RAS-acting Agents Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America RAS-acting Agents Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa RAS-acting Agents Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa RAS-acting Agents Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa RAS-acting Agents Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa RAS-acting Agents Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa RAS-acting Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. RAS-acting Agents Market Drivers
Figure 77. RAS-acting Agents Market Restraints
Figure 78. RAS-acting Agents Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of RAS-acting Agents in 2022
Figure 81. Manufacturing Process Analysis of RAS-acting Agents
Figure 82. RAS-acting Agents Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source